Longeveron is a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions.
View all
Second Genome
South San Francisco, United States · Grant
Aridis Pharmaceutical
San Jose, United States · Post IPO Equity
Seeding Labs
Boston, United States · Grant
Caladrius Biosciences
Basking Ridge, United States · IPO
Sanguine
Los Angeles, United States · Grant
Envisagenics
New York, United States · Grant
Paradromics
San Jose, United States · Venture
New Age Meats
Berkeley, United States · Series A
Lantern Pharma
Dallas, United States · IPO
Raptor Maps
Somerville, United States · Series B
ECHO
San Diego, United States · Series A
HistoWiz
NY, United States · Series A